Verzenio plus endocrine therapy reduced death risk by 15.8% in high-risk early breast cancer patients compared to endocrine ...

Dual subspecialty training in Med-Peds endocrinology is a four-year pathway. The first two years of fellowship are dedicated to clinical training, with clinical rotations divided between adult and ...

We are delighted you are interested in our clinical, scientific, and educational missions. Whether you are a prospective patient, trainee, or collaborator, we invite you to explore all that we offer ...

GLP-1 receptor agonists show promise in treating various chronic conditions, but potential risks and unanswered questions remain for care of patients with NETs.

Adults with prediabetes and overweight or obesity had similar success in maintaining an HbA1c of less than 6.5% with an ...

Abemaciclib plus endocrine therapy significantly improved overall survival, IDFS, and DRFS in HR-positive, HER2-negative, node-positive early breast cancer. Adjuvant abemaciclib (Verzenio; Eli Lilly) ...

More than 1,200 interns, residents and fellows train in every medical specialty at the University of Alabama at Birmingham campus and at our regional campuses in Montgomery, Huntsville, Tuscaloosa and ...

Yale University School of Medicine today announced the appointment of Robert Udelsman as the school’s new chair of surgery. Udelsman was most recently the Richard Bennett Darnall Professor of Surgery ...

The Endocrine Society rebukes the Florida Board of Medicine's decision to ban gender-affirming care for transgender and gender-diverse teenagers. We call on the Florida Board of Medicine to reverse ...